Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis.

MLA

Deng, Jiawen, et al. “Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in COVID-19 Management: A Systematic Review and Meta-Analysis.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, no. 5, May 2023, pp. 578–86. EBSCOhost, https://doi.org/10.1016/j.cmi.2023.01.010.

APA

Deng, J., Rayner, D., Ramaraju, H. B., Abbas, U., Garcia, C., Heybati, K., Zhou, F., Huang, E., Park, Y.-J., & Moskalyk, M. (2023). Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 29(5), 578–586. https://doi.org/10.1016/j.cmi.2023.01.010

Chicago

Deng, Jiawen, Daniel Rayner, Harikrishnaa B Ramaraju, Umaima Abbas, Cristian Garcia, Kiyan Heybati, Fangwen Zhou, Emma Huang, Ye-Jean Park, and Myron Moskalyk. 2023. “Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in COVID-19 Management: A Systematic Review and Meta-Analysis.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 29 (5): 578–86. doi:10.1016/j.cmi.2023.01.010.